Design and experimental activities supporting commercial U.S. electron accelerator production of Mo-99.

Autor: Dale, Gregory E., Chemerisov, Sergey D., Vandegrift, George F., Woloshun, Keith A., Kelsey IV, Charles T., Tkac, Peter, Makarashvili, Vakho, Jonah, Charles D., Olivas, Eric R., Holloway, Michael A., Hurtle, Ken P., Romero, Frank P., Dalmas, Dale A., Harvey, James T.
Předmět:
Zdroj: AIP Conference Proceedings; Apr2013, Vol. 1525 Issue 1, p355-359, 5p, 1 Black and White Photograph, 4 Diagrams
Abstrakt: 99mTc, the daughter isotope of 99Mo, is the most commonly used radioisotope for nuclear medicine in the United States. Under the direction of the National Nuclear Security Administration (NNSA), Los Alamos National Laboratory (LANL) and Argonne National Laboratory (ANL) are partnering with North Star Medical Technologies to demonstrate the viability of large-scale 99Mo production using electron accelerators. In this process, 99Mo is produced in an enriched 100Mo target through the 100Mo(γ,n)99Mo reaction. Five experiments have been performed to date at ANL to demonstrate this process. This paper reviews the current status of these activities, specifically the design and performance of the helium gas target cooling system. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index